Pediatric Respiratory Illness Measurement System (PRIMES) Implementation in Community Hospital Settings

儿科呼吸疾病测量系统 (PRIMES) 在社区医院的实施

基本信息

项目摘要

Acute respiratory illness is a major cause of hospitalizations in the pediatric population with over 75% of admissions occurring in community–based (non-children's) hospitals. Focusing inpatient quality improvement (QI) efforts on these conditions is likely to have a significant impact on outcomes. The Pediatric Respiratory Illness Measurement System-Short Version (PRIMES-SV) tool is an abbreviated version of the previously developed and validated PRIMES quality assessment tool. Using medical records data, PRIMES-SV generates quality scores for both asthma and bronchiolitis, two of the most common conditions diagnosed in children admitted to community hospitals. The overall goals of this study are to demonstrate the sensitivity of PRIMES-SV measures to quality improvement (QI) interventions in community hospital settings, and to better understand the contextual and provider-level factors associated with both the ability to improve performance and to sustain those improvements. The specific aims of the study are: Aim 1. To implement the PRIMES-SV tool in six geographically diverse community hospitals to a) examine the degree of variation in performance across the hospitals and b) identify implementation barriers to high performance using the Consolidated Framework for Implementation Research (CFIR); Aim 2.To a) conduct a QI collaborative and improve overall performance on a sub-set of PRIMES-SV measures among the six hospitals by targeting CFIR-linked barriers with aligned strategies, and b) assess whether improved performance is associated with decreased LOS and costs; and Aim 3. To a) assess whether observed performance improvements are sustained on the targeted PRIMES-SV measures and b) determine which CFIR factors are linked with sustainment. These aims will be accomplished by bringing together a diverse group of experts in the fields of QI evaluation research, implementation science, and pediatric community-based hospital medicine. If using the proposed approach to QI is successful and improvements are sustained, the PRIMES-SV quality assessment tool used in combination with CFIR barrier-strategy matching could be widely disseminated to both community and children's hospitals to facilitate quality improvement for these common and high cost pediatric conditions.
急性呼吸道疾病是儿科人群住院的主要原因,75%以上的儿童 在以社区为基础的(非儿童)医院入院。着力提高住院病人质量 在这些条件下所做的努力可能会对结果产生重大影响。儿科呼吸系统 疾病测量系统-简写版本(PRIMES-SV)工具是以前 开发并验证PRIMES质量评估工具。使用医疗记录数据,PRIMES-SV 为哮喘和毛细支气管炎生成质量分数,这是在 儿童被送往社区医院。这项研究的总体目标是证明 PRIMES-SV对社区医院环境中的质量改进(QI)干预措施,以及更好的 了解与提高性能的能力相关的背景因素和提供商级别的因素 并维持这些进步。 研究的具体目标是:目标1.在六个地理位置不同的地区实施PRIMES-SV工具 社区医院:a)检查各医院绩效的差异程度;b)确定 使用实施研究综合框架实现高性能的实施障碍 (CFIR);目标2)在PRIMES-SV子集上进行QI协作并提高整体绩效 在六家医院之间采取措施,目标是与CFIR相关的障碍,并制定一致的战略,以及b)评估 改进的性能是否与降低的损失和成本相关;以及目标3)评估 观察到的绩效改进在目标PRIMES-SV措施上持续存在,并且b)确定 哪些CFIR因素与可持续发展有关。 这些目标将通过聚集QI领域的不同专家小组来实现 评价研究、实施科学和儿科社区医院医学。如果使用 提出的QI方法是成功的,并且持续改进,PRIMES-SV质量评估 结合CFIR障碍-策略匹配使用的工具可以广泛传播到这两个社区 和儿童医院,以促进改善这些常见和高成本的儿科疾病的质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RITA MANGIONE-SMITH其他文献

RITA MANGIONE-SMITH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RITA MANGIONE-SMITH', 18)}}的其他基金

Pediatric Respiratory Illness Measurement System (PRIMES) Implementation in Community Hospital Settings
儿科呼吸疾病测量系统 (PRIMES) 在社区医院的实施
  • 批准号:
    10689215
  • 财政年份:
    2021
  • 资助金额:
    $ 71.19万
  • 项目类别:
Dialogue Around Respiratory Illness Treatment
围绕呼吸系统疾病治疗的对话
  • 批准号:
    9335183
  • 财政年份:
    2015
  • 资助金额:
    $ 71.19万
  • 项目类别:
Pediatric Respiratory Illness Inpatient Measurement System Study
儿科呼吸系统疾病住院测量系统研究
  • 批准号:
    8822918
  • 财政年份:
    2014
  • 资助金额:
    $ 71.19万
  • 项目类别:
Pediatric Respiratory Illness Inpatient Measurement System Study
儿科呼吸系统疾病住院测量系统研究
  • 批准号:
    8612679
  • 财政年份:
    2014
  • 资助金额:
    $ 71.19万
  • 项目类别:
Pediatric Quality Improvement Methods, Research and Evaluation Conference, Advanc
儿科质量改进方法,研究与评估会议,Advanc
  • 批准号:
    8491212
  • 财政年份:
    2013
  • 资助金额:
    $ 71.19万
  • 项目类别:
Center of Excellence on Quality of Care Measures for Children with Complex Needs
复杂需求儿童护理质量卓越中心
  • 批准号:
    8104916
  • 财政年份:
    2011
  • 资助金额:
    $ 71.19万
  • 项目类别:
Center of Excellence on Quality of Care Measures for Children with Complex Needs
复杂需求儿童护理质量卓越中心
  • 批准号:
    8639464
  • 财政年份:
    2011
  • 资助金额:
    $ 71.19万
  • 项目类别:
Center of Excellence on Quality of Care Measures for Children with Complex Needs
复杂需求儿童护理质量卓越中心
  • 批准号:
    8436130
  • 财政年份:
    2011
  • 资助金额:
    $ 71.19万
  • 项目类别:
Center of Excellence on Quality of Care Measures for Children with Complex Needs
复杂需求儿童护理质量卓越中心
  • 批准号:
    8232542
  • 财政年份:
    2011
  • 资助金额:
    $ 71.19万
  • 项目类别:
Improving Asthma Outcomes Through Spirometry Distance Learning
通过肺活量测定远程学习改善哮喘结果
  • 批准号:
    8278603
  • 财政年份:
    2010
  • 资助金额:
    $ 71.19万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 71.19万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了